NanoCellect Biomedical
PrivateLast Round
VC Round
Jun 29, 2023
Total Funding Raised
$50.28M
Company Overview
NanoCellect Biomedical is a biotechnology company that develops microfluidic flow cytometry devices to simplify cell analysis and sorting for biomedical research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoCellect Biomedical Comparables
Compare NanoCellect Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| On-chip Biotechnologies Co., Ltd. | 86% | |
| Deepcell | 83% | |
| ThinkCyte | 81% |
NanoCellect Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 29, 2023 | ||||
| Grant | Aug 24, 2022 | ||||
| Series D | Aug 1, 2021 | ||||
| Grant | Oct 4, 2019 | ||||
| Series B | Nov 28, 2017 | ||||
Series A | Feb 4, 2016 |
NanoCellect Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Genoa Ventures | Series B |
| FusionX Ventures | Series C, Series B, Series D, Series A |
| Anzu Partners | Series B, Series D |
| Vertical Venture Partners | Series B, Series D, Series C |
| Casdin Capital | Series D |
| Warburg Pincus | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2021
$20M round led by Warburg Pincus.
- Sep 1, 2015
$225K grant received from NIH RADx.
Recent news
Latest coverage and updates
- is_developingJul 24, 2026
NanoCellect Biomedical, Inc. is developing microfluidic cell sorting technologies.
- sells_assets_toJul 24, 2026
NanoCellect Biomedical, Inc. sold assets to Nova Biomedical Incorporated on Jul 24th '26.
NanoCellect Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NanoCellect Biomedical's valuation, stock price, and market status.
Is NanoCellect Biomedical a public or private company?
NanoCellect Biomedical is a private company.
What is the current stock price of NanoCellect Biomedical?
NanoCellect Biomedical is a private company with no public stock price. No recent secondary market data is available.
How much is NanoCellect Biomedical worth (valuation)?
Valuation information for NanoCellect Biomedical is not publicly available.
Can I buy NanoCellect Biomedical stock?
NanoCellect Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NanoCellect Biomedical's last funding round?
NanoCellect Biomedical's most recent funding round was VC Round on June 29, 2023.
Who are the main investors in NanoCellect Biomedical?
Key investors in NanoCellect Biomedical include FusionX Ventures, Illumina Ventures.
Will NanoCellect Biomedical IPO soon?
No public IPO plans have been announced for NanoCellect Biomedical.
How can I track NanoCellect Biomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoCellect Biomedical's secondary market activity and sign up for updates.